Navigation Links
With cochlear implants, earlier use leads to better speech

uggest that by age 4 and a half, children who had cochlear implants very early often have normal speech and can potentially enter kindergarten with their hearing peers.

"Kids with residual hearing can get some help from hearing aids, but cochlear implants give a tremendous hearing advantage over hearing aids -- the implants provide more sound information," Nicholas says. "For example, high-frequency sounds are magnified more with cochlear implants, so kids can hear 's' sounds and 'ed' endings better. So they tend to catch on to plurals and verb tenses faster."

While studies like this and others favor early implantation, the decision for or against cochlear implantation is frequently put off, Nicholas indicates. Hearing parents often find they need time to learn about deafness and potential treatments. Implantation also may be delayed to make certain an infant's deafness has not been misdiagnosed.

Even when deafness is confirmed, the idea of head surgery for their baby makes many parents hesitate. And they may be daunted by the fact that a cochlear implant is forever -- the device destroys any residual hearing so that hearing aids are no longer an option.

"Studies like ours are meant to help answer parents' questions about cochlear implants," Nicholas says. "Our overall goal is to focus on the best age for implantation. If the window of time for the best outcome is small, we want parents to know that. With the results we've seen so far, we believe that it is best to implant when the child is younger than 24 months if parents want a deaf child to use spoken language at the same level as their hearing peers."

Nicholas is also on the faculty of the Program in Audiology and Communication Sciences (PACS) at Washington University School of Medicine. The PACS program is part of a consortium of programs formerly operated by Central Institute for the Deaf and now collectively known as CID at Washington University School of Medicine
'"/>

Source:Washington University School of Medicine


Page: 1 2 3

Related biology news :

1. Sooner is better with cochlear implants, Stanford scientist shows
2. Asymptomatic HIV babies could use earlier treatment
3. Making a face: A new and earlier marker of neural crest development
4. Study of genomic DNA leads to new advances in cancer diagnostics
5. Combination therapy leads to partial recovery from spinal cord injury in rats
6. Chemical guidance of T cells leads to immunologic memory and long-term immunity
7. Basic research leads to a novel cancer therapy
8. Less antibiotic use in food animals leads to less drug resistance in people, study shows
9. MBL leads effort to update E. coli genome
10. Pest control research leads to pain control discovery
11. UT Southwestern researchers find gene mutation that leads to broken hearts
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: With cochlear implants earlier use leads better speech

(Date:4/13/2015)... -- higi, a leading cloud-based consumer engagement platform that provides ... their communities around health and wellness, announced today the ... ... convenient vehicle to receive validated health information from consumers. ... API will allow higi,s trusted partners, on a user ...
(Date:4/2/2015)... 2015 In the current ... outperforms the strongest competitors, showing outstanding performance in ... system is capable of a throughput of 5.000.000 ... to be ten times faster than most competitors ...      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ) ...
(Date:4/1/2015)... April 1, 2015   Medisafe ™, the leading ... across iOS and Android smartphones ... biofeedback into the platform to allow patients to track ... the first time, patients will be able to visualize ... impacts important biometrics, such as glucose levels and blood ...
Breaking Biology News(10 mins):higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2
... release is available in German . , In ... immune system must be able to recognize myriad different foreign ... Institute of Immunobiology and the Centre for Biological Signalling Studies ... immune system,s B-cells can be activated by numerous substances from ...
... know about smoking, diet, exercise and available methods ... approximately half of all cancers nationwide. ... will host its Ninth Annual International Conference on ... Convention Center, located in Philadelphia. Thousands of scientists ...
... new study from North Carolina State University finds that fish ... than fish that live much further away. The surprising finding ... selenium, found near such facilities, which unfortunately poses problems of ... at least 30 kilometers (km) from a coal-fired power plant ...
Cached Biology News:One lock, many keys 2Study: Fish near coal-fired power plants have lower levels of mercury 2
(Date:4/27/2015)... , Alemania, April 27, 2015 ... nuevo receptor utilizando tecnología de descubrimiento de biomarcador computacional  ... el tratamiento de millones de pacientes con cáncer   ... ha recibido una patente en Europa titulada "Tissue Protective ... Molecular Health de que EPHB4 es un nuevo receptor ...
(Date:4/27/2015)... 2015 Dr. Robert Hanzlik, whose groundbreaking ... carries implications for advancing the creation of safer pharmaceuticals, ... National University , the second-largest private, nonprofit university in ... a professor at the University of Kansas School of ... starts at 5 p.m. and takes place at National ...
(Date:4/27/2015)... April 27, 2015  Edico Genome today announced ... from Harvard and Stanford Universities showed the DRAGEN™ ... sequence with 300x depth of coverage by tenfold, ... 60 hours with standard software. "Processing ... especially for individual research and clinical labs, in ...
(Date:4/27/2015)... 2015 Deadly viruses such as Ebola ... of the University City Science Center's Port ... , With a $4.5 million Phase 2 SBIR grant ... Phelix Therapeutics is focused on therapies for unmet ... company is developing first-in-class protease inhibitors based on a ...
Breaking Biology Technology:Molecular Health obtiene la patente para un nuevo receptor 2Molecular Health obtiene la patente para un nuevo receptor 3Dr. Robert Hanzlik Discusses Pharmaceutical Testing Models at Event Hosted by National University 2Dr. Robert Hanzlik Discusses Pharmaceutical Testing Models at Event Hosted by National University 3Edico Genome, in Collaboration with Researchers from Harvard and Stanford Universities, Speeds Analysis of Whole Genome Sequence with 300x Depth of Coverage Tenfold 2Edico Genome, in Collaboration with Researchers from Harvard and Stanford Universities, Speeds Analysis of Whole Genome Sequence with 300x Depth of Coverage Tenfold 3New Resident of Science Center’s Port Business Incubator Targets SARS and Ebola 2
... Cephalon, Inc., (Nasdaq: CEPH ) will hold a public ... late Chairman and CEO on February 1, 2011, at 6:00 p.m. ... Pennsylvania. Dr. Baldino founded Cephalon in 1987 and ... the top ten biotechnology companies in the world. He was a ...
... SHANGHAI, Jan. 24, 2011 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. ("China-Biotics" ... leading developer, manufacturer and distributor of probiotics products in ... 2011 third quarter ended December 31, 2010. ... between $32 million and $33 million compared with $23 ...
... Jan. 24, 2011 RRD International, a strategy-driven biotech ... has entered into a partnership with the National Institutes ... (TRND) program as a regulatory support and development partner. ... focus on two rare disease drug development projects: Hereditary ...
Cached Biology Technology:Cephalon to Hold Public Memorial Service to Celebrate the Life of Company Founder, Frank Baldino, Jr., Ph.D. 2China-Biotics, Inc. Provides Preliminary FY2011Third Quarter Revenue 2China-Biotics, Inc. Provides Preliminary FY2011Third Quarter Revenue 3RRD Selected as Development Partner for NIH Therapeutics for Rare and Neglected Diseases Program 2RRD Selected as Development Partner for NIH Therapeutics for Rare and Neglected Diseases Program 3